GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-12-22. The company creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable development partners that will assist it in preparing its cannabinoid-based formulas for the treatment of the motor symptoms of Parkinson's disease in human clinical trials. The company is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. GBSGB’s has a portfolio of intellectual property containing both proprietary plant-inspired formulations and its artificial intelligence-enabled drug discovery platform, and critical research contracts and key supplier arrangements. Its intellectual property covers a range of 65 medical conditions.
GBLX stock price ended at $0 on Wednesday, after rising NaN%
On the latest trading day Apr 01, 2026, the stock price of GBLX rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 83.1K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 38.8K shares were traded, amounting to a market value of approximately --.
GBLX Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 6
Sell Signals 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
GBLX currently exhibits 0 buy signals and 1 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Sell outlook for the mid-term.
Bullish/Bearish Signals for GBLX
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for GBLX. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to GBLX?
According to technical analysis, GB Sciences Inc has an aggregate signal of Sell. GB Sciences Inc has 0 Buy signals, 6 Neutral Signals and 1 sell signals.
What are the Fibonacci retracement levels for GBLX?
The Fibonacci retracement level for GB Sciences Inc is between 0% and 23.6%
What is the RSI for GB Sciences Inc?
The RSI for GB Sciences Inc is currently 42.87, indicating a neutral condition
What is GB Sciences Inc price for the next 12 months?
GB Sciences Inc GBLX price for the next 12 months is estimated at $0.
How high is GB Sciences Inc expected to go?
According to wall street analysts, GB Sciences Inc is expected to reach a high forecast of $0.